NCT07296471 (OP-MultiOmics) is a clinical trial in Primary Osteoporosis, sponsored by Dr. Li Chen.

Who is sponsoring NCT07296471?

NCT07296471 is sponsored by Dr. Li Chen.

What condition does NCT07296471 study?

NCT07296471 studies Primary Osteoporosis.

Is NCT07296471 still recruiting?

NCT07296471 is currently recruiting now. Last updated 22 December 2025.

Last reviewed 2025-12-22 · How we verify

NCT07296471: OP-MultiOmics

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin D Status and Multi-Omics Profiles in Primary Osteoporosis

Recruiting now Last updated 22 December 2025

What this trial tests

trial in Primary Osteoporosis in 120 participants. Currently enrolling.

Timeline

11 November 2025

Primary endpoint
30 November 2027

30 November 2027

Quick facts

Lead sponsor	Dr. Li Chen
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	120
Start date	11 November 2025
Primary completion	30 November 2027
Estimated completion	30 November 2027
Sites	1 location across China

Conditions studied

Primary Osteoporosis — all drugs for Primary Osteoporosis →

Sponsor

Dr. Li Chen

Who can join

18 and older, any sex, with Primary Osteoporosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study aims to explore the relationships between vitamin D status and genomic, proteomic, and metabolomic profiles in patients with primary osteoporosis. Eligible participants are adults who are newly diagnosed with primary osteoporosis at Yichang Second People's Hospital. Blood samples will be collected at the initial diagnosis to analyze gene expression, protein levels, and metabolic profiles. Participants will receive standard clinical treatment according to routine care, but no additional research sampling or follow-up will be performed. The study seeks to identify molecular patterns associated with osteoporosis and improve understanding of patient responses to therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Primary Osteoporosis

Currently open trials in the same condition.

NCT07506538 — Community Smart Aging Model - Resistance Training · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07296471 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. Li Chen
Last refreshed: 22 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07296471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing